Bloomage BioTechnology Corporation Limited reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 6,359.19 million compared to CNY 4,947.77 million a year ago. Net income was CNY 970.11 million compared to CNY 782.33 million a year ago.

Basic earnings per share from continuing operations was CNY 2.02 compared to CNY 1.63 a year ago.